Grant Amount: NIDA intends to commit $2M in FY 2014 to fund 2-3 awards.
This FOA will support highly innovative R01 applications on HIV/AIDS and drug abuse and will complement the Avant-Garde Award Program for HIV/AIDS research. The Avant-Garde award http://ww2.drugabuse.gov/about/organization/arp/AVGP.htm supports individuals who conduct high-risk, high-payoff research and does not require a detailed research plan. Applications submitted under this FOA are required to have a detailed research plan and preliminary data. This FOA focuses on innovative research projects that have the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among substance abusers. The nexus with substance abuse should be clearly described. This FOA is open to both individual researchers and research teams and is not limited to any one area of research.
This FOA seeks to attract exceptionally talented investigators to conduct innovative, potentially groundbreaking and/or unconventional investigations on HIV/AIDS and substance abuse. Projects may be led by collaborative investigative teams or individual scientists. Awards will support projects, which, if successful, will have a major impact on HIV/AIDS and substance abuse. Examples of studies of relevance to drug abuse would include: studies using populations with significant numbers of drug users or samples from drug using populations; studies using in vitro systems and/or animal models that test the effects of drugs of abuse on HIV pathogenesis, progression, or treatment; and studies to develop interventions or treatments that are tailored to substance using populations. Projects may be in any area of research but must be in an area described in the Trans – NIH Plan for HIV-Related Researchhttp://www.oar.nih.gov/strategicplan/. While not limited to any one area of research, this award is well suited to conducting translational studies. However, studies are not required to include a translational element. This FOA is designed to complement NIDA's existing Avant-Garde Award Program for HIV/AIDS Research, which focuses on individual researchers and which does not require a detailed research plan. In contrast, this FOA focuses on innovative research projects, and applications to this FOA are required to have a detailed research plan and preliminary data. Applications submitted under this FOA should clearly exhibit creativity, innovativeness, and risk.
National Institute on Drug Abuse
City Agencies Colleges/Universities Commercial Organizations Community Based Organizations County Agencies Educational Organizations/Institutions Federal Government Agencies International Agencies IRS 501 (c)(3) Organizations Nonprofit Organizations Religious Organizations Schools State Agencies Tribal Organizations
Number of Awards Given
2 to 3 awards
Award Amount Notes
NIDA intends to commit $2M in FY 2014 to fund 2-3 awards.
Drug Abuse HIV/AIDS Prevention Medical Treatments and Therapies Research Programs
Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this FOA or following the directions provided at Grants.gov.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf), except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.